The Potential Clinical Use of Stem/Progenitor Cells and Organoids in Liver Diseases
Open Access
Abstract
The liver represents the most important metabolic organ of the human body. It is evident that an imbalance of liver function can lead to several pathological conditions, known as liver failure. Orthotropic liver transplantation (OLT) is currently the most effective and established treatment for end-stage liver diseases and acute liver failure (ALF). Due to several limitations, stem-cell-based therapies are currently being developed as alternative solutions. Stem cells or progenitor cells derived from various sources have emerged as an alternative source of hepatic regeneration. Therefore, hematopoietic stem cells (HSCs), mesenchymal stromal cells (MSCs), endothelial progenitor cells (EPCs), embryonic stem cells (ESCs) and induced pluripotent stem cells (iPSCs) are also known to differentiate into hepatocyte-like cells (HPLCs) and liver progenitor cells (LPCs) that can be used in preclinical or clinical studies of liver disease. Furthermore, these cells have been shown to be effective in the development of liver organoids that can be used for disease modeling, drug testing and regenerative medicine. In this review, we aim to discuss the characteristics of stem-cell-based therapies for liver diseases and present the current status and future prospects of using HLCs, LPCs or liver organoids in clinical trials.Keywords
Funding Information
- Hellenic Foundation of Research and Innovation (16468)
This publication has 111 references indexed in Scilit:
- Recent advances in 2D and 3D in vitro systems using primary hepatocytes, alternative hepatocyte sources and non-parenchymal liver cells and their use in investigating mechanisms of hepatotoxicity, cell signaling and ADMEArchives of Toxicology, 2013
- Outcomes in partial liver transplantation: deceased donor split-liver vs. live donor liver transplantationHPB, 2011
- Is Human Fetal Liver Stem Cell Transplantation a Panacea for Alcohol-Induced Liver Decompensation?Cell Transplantation, 2011
- Self-Organization of Animal Tissues: Cadherin-Mediated ProcessesDevelopmental Cell, 2011
- Dispensing pico to nanolitre of a natural hydrogel by laser-assisted bioprintingBioMedical Engineering OnLine, 2011
- Barriers to the successful treatment of liver disease by hepatocyte transplantationJournal of Hepatology, 2010
- Potentials of regenerative medicine for liver diseaseSurgery Today, 2009
- Improvement of liver function in liver cirrhosis patients after autologous mesenchymal stem cell injection: a phase I–II clinical trialEuropean Journal of Gastroenterology & Hepatology, 2009
- Study of Impact-Induced Mechanical Effects in Cell Direct Writing Using Smooth Particle Hydrodynamic MethodJournal of Manufacturing Science and Engineering, 2008
- Minimal criteria for defining multipotent mesenchymal stromal cells. The International Society for Cellular Therapy position statementCytotherapy, 2006